Read + Share
Amedeo Smart
Independent Medical Education
Han X, Ding C, Zhang G, Pan R, et al. Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway. Biochem Biophys Res Commun 2020;525:895-901.PMID: 32171530
Email
LinkedIn
Facebook
Twitter
Privacy Policy